🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)
This product: 160mg

Other Ingredients

Olive Oil Gelatin Glycerin Caramel color Titanium Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult Male (18-50 Years) Seniors/Mature (>50 Years) - Men ONLY

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one softgel capsule twice daily with water at mealtime.

⚠️ Warnings & Precautions

Discontinue use two weeks prior to surgery.

KEEP OUT OF REACH OF CHILDREN.

WARNING: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

🧪 Formulation Notes

Standardized Extract ? 160 mg

No Sugar, No Starch, No Artificial Colors, No Artificial Flavors, No Preservatives, Sodium Free, No Wheat, No Gluten, No Corn, No Soy, No Dairy, Yeast Free.

Additional Information

Store in a cool, dry place.

CODE 397231 EKG

Potencies verified by GNC procedure #5123 and #5363.

Supports Healthy Prostate Function*

Product Details

UPC / SKU 0 48107 06890 5
DSLD Entry Date 2011-10-26
Product Type Botanical
Form Softgel Capsule
DSLD ID 853
Data Updated 2026-04-11

Research Evidence

35 Research Sources
52 Avg Quality Score
15 Meta Analysis
11 Systematic Review
7 Rct
1 Narrative Review
1 Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009
View all evidence for Saw Palmetto →

Compare Similar Products

View all Saw Palmetto products →